Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Limited



Quote for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Limited

Last Trade:
-
Change:
--
Symbol/Code:
08231
Status:
-
Type:
H Share
P/E:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume:
-
Amount:
-
Day's Range:
-
52 week Range:
-
Update:-
Quote Delayed 15 Min.
Currency in HKD Time=UTC+808231 quote

Summary for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Limited

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, is engaged in the research, development and selling of self-developed bio-pharmaceutical know-how, carrying out contracted research for customers, manufacturing and selling of medical products and the provision of related ancillary services in the People's Republic of China. As of December 31, 2010, the Company had direct interests of 100%, 65% and 69.77% in three subsidiaries, Shanghai Morgan-Tan International Center for Life Sciences, Co., Ltd. (Morgan-Tan), Shanghai Ba Dian Medicine Co., Ltd. (Ba Dian) and Taizhou Fudan-Zhangjiang Pharmaceutical Co., Ltd. (Taizhou Pharmaceutical), respectively. Morgan- Tan is engaged in research and development of specialized bio-pharmaceutical projects and provision of related services. During the year ended December 31, 2010, the Company acquired all of Shanghai Zhangjiang (Group) Co., Ltd.'s (SZCL) 31.25% interests in the Company's subsidiary Morgan-Tan.